Complement receptor 2 downregulation is associated with mortality in Staphylococcus aureus sepsis in both mice and humans - Summary - MDSpire

Complement receptor 2 downregulation is associated with mortality in Staphylococcus aureus sepsis in both mice and humans

  • By

  • Pradeep Kumar Kopparapu

  • Meghshree Deshmukh

  • Santhilal Subhash

  • Majd Mohammad

  • Zhicheng Hu

  • Anders Jarneborn

  • Muhammad Arif

  • Marcela Pekna

  • Lars Ljungström

  • Gunnar Jacobsson

  • Ola Grimsholm

  • Tao Jin

  • July 9, 2026

  • 0 min

Share

Objective:

To identify biomarkers associated with mortality in Staphylococcus aureus sepsis through transcriptomic analysis in a murine model and validation in human patients.

Approach:
  • Murine Model: Conducted transcriptomic analysis in a murine model of S. aureus sepsis to identify genes distinguishing survivors from fatalities.
  • Human Validation: Evaluated identified candidate genes, particularly CR2, in patients with severe invasive bacterial infections.
Key Findings:
  • Complement receptor 2 (CR2) was significantly downregulated in deceased patients compared to survivors and healthy controls.
  • CR2 downregulation correlated with disease severity and was independent of complement factor 3, TLR2, and TNF-α.
  • B-cell depletion and CR2 downregulation were observed over time in infected mice.
Interpretation:

CR2 downregulation may reflect immune dysregulation associated with severe S. aureus infection and mortality.

Limitations:
  • The study primarily focuses on a murine model, which may not fully replicate human sepsis.
  • Further validation in larger clinical cohorts is necessary to confirm findings.
Conclusion:

CR2 downregulation is associated with severe infection and mortality in S. aureus sepsis.

Original Source(s)

Related Content